99 related articles for article (PubMed ID: 30116813)
1. Building of neomycin-nucleobase-amino acid conjugates for the inhibition of oncogenic miRNAs biogenesis.
Vo DD; Becquart C; Tran TPA; Di Giorgio A; Darfeuille F; Staedel C; Duca M
Org Biomol Chem; 2018 Aug; 16(34):6262-6274. PubMed ID: 30116813
[TBL] [Abstract][Full Text] [Related]
2. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates.
Vo DD; Tran TP; Staedel C; Benhida R; Darfeuille F; Di Giorgio A; Duca M
Chemistry; 2016 Apr; 22(15):5350-62. PubMed ID: 26928593
[TBL] [Abstract][Full Text] [Related]
4. Modulation of oncogenic miRNA biogenesis using functionalized polyamines.
Staedel C; Tran TPA; Giraud J; Darfeuille F; Di Giorgio A; Tourasse NJ; Salin F; Uriac P; Duca M
Sci Rep; 2018 Jan; 8(1):1667. PubMed ID: 29374231
[TBL] [Abstract][Full Text] [Related]
5. Assessment of new triplet forming artificial nucleobases as RNA ligands directed towards HCV IRES IIId loop.
Safir Filho M; Martin AR; Benhida R
Bioorg Med Chem Lett; 2017 Apr; 27(8):1780-1783. PubMed ID: 28274634
[TBL] [Abstract][Full Text] [Related]
6. A pH Sensitive High-Throughput Assay for miRNA Binding of a Peptide-Aminoglycoside (PA) Library.
Watkins D; Jiang L; Nahar S; Maiti S; Arya DP
PLoS One; 2015; 10(12):e0144251. PubMed ID: 26656788
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer.
Tsai KW; Hu LY; Chen TW; Li SC; Ho MR; Yu SY; Tu YT; Chen WS; Lam HC
Oncol Rep; 2015 Jan; 33(1):485-93. PubMed ID: 25394359
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer.
Wang J; Wang Q; Liu H; Hu B; Zhou W; Cheng Y
Cancer Lett; 2010 Nov; 297(2):137-43. PubMed ID: 20797817
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
He XP; Shao Y; Li XL; Xu W; Chen GS; Sun HH; Xu HC; Xu X; Tang D; Zheng XF; Xue YP; Huang GC; Sun WH
FEBS J; 2012 Nov; 279(22):4201-12. PubMed ID: 23013439
[TBL] [Abstract][Full Text] [Related]
10. Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
Tran TP; Vo DD; Di Giorgio A; Duca M
Bioorg Med Chem; 2015 Sep; 23(17):5334-44. PubMed ID: 26264847
[TBL] [Abstract][Full Text] [Related]
11. Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis.
Chaulk SG; Thede GL; Kent OA; Xu Z; Gesner EM; Veldhoen RA; Khanna SK; Goping IS; MacMillan AM; Mendell JT; Young HS; Fahlman RP; Glover JN
RNA Biol; 2011; 8(6):1105-14. PubMed ID: 21955497
[TBL] [Abstract][Full Text] [Related]
12. Development of 2-deoxystreptamine-nucleobase conjugates for the inhibition of oncogenic miRNA production.
Tran TPA; Poulet S; Pernak M; Rayar A; Azoulay S; Di Giorgio A; Duca M
RSC Med Chem; 2022 Mar; 13(3):311-319. PubMed ID: 35434630
[TBL] [Abstract][Full Text] [Related]
13. Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents.
Joly JP; Mata G; Eldin P; Briant L; Fontaine-Vive F; Duca M; Benhida R
Chemistry; 2014 Feb; 20(7):2071-9. PubMed ID: 24431237
[TBL] [Abstract][Full Text] [Related]
14. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
Shi Z; Zhang J; Qian X; Han L; Zhang K; Chen L; Liu J; Ren Y; Yang M; Zhang A; Pu P; Kang C
Cancer Res; 2013 Sep; 73(17):5519-31. PubMed ID: 23811941
[TBL] [Abstract][Full Text] [Related]
15. Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.
Shinozaki-Ushiku A; Kunita A; Isogai M; Hibiya T; Ushiku T; Takada K; Fukayama M
J Virol; 2015 May; 89(10):5581-91. PubMed ID: 25740983
[TBL] [Abstract][Full Text] [Related]
16. miR-107 and miR-25 simultaneously target LATS2 and regulate proliferation and invasion of gastric adenocarcinoma (GAC) cells.
Zhang M; Wang X; Li W; Cui Y
Biochem Biophys Res Commun; 2015 May; 460(3):806-12. PubMed ID: 25824045
[TBL] [Abstract][Full Text] [Related]
17. Primary analysis and screening of microRNAs in gastric cancer side population cells.
Zhang HH; Gu GL; Zhang XY; Li FZ; Ding L; Fan Q; Wu R; Shi W; Wang XY; Chen L; Wei XM; Yuan XY
World J Gastroenterol; 2015 Mar; 21(12):3519-26. PubMed ID: 25834316
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
Eun JW; Kim HS; Shen Q; Yang HD; Kim SY; Yoon JH; Park WS; Lee JY; Nam SW
J Pathol; 2018 Jan; 244(1):107-119. PubMed ID: 28991363
[TBL] [Abstract][Full Text] [Related]
19. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
20. A tale of two targets: differential RNA selectivity of nucleobase-aminoglycoside conjugates.
Blount KF; Tor Y
Chembiochem; 2006 Oct; 7(10):1612-21. PubMed ID: 16915600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
